Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Siepmann

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Deutsche Medizinische Wochenschrift (1946)|December 23, 1994
[Sicca symptoms during systemic therapy with beta-receptor blockers]M Siepmann, J Barth, W Kirch
Medizinische Klinik (Munich, Germany : 1983)|January 15, 1996
[Drug-induced cerebrovascular infarct]U Ebert, M Siepmann, W Kirch
Deutsche Medizinische Wochenschrift (1946)|June 14, 2013
[Medical care of patients with Behçet's disease]A Eichhorn, M Siepmann, W Kirch
British Journal of Clinical Pharmacology|May 1, 1995
The interaction of the calcium antagonist RO 40-5967 with digoxinM Siepmann, C Kleinbloesem, W Kirch
Journal of Cardiovascular Pharmacology|June 1, 1995
Hemolysis on intravenous administration of a new calcium antagonistC H Kleinbloesem, M Siepmann, W Kirch
Clinical Drug Investigation|August 14, 2016
Disposition, Elimination and Haemodynamic Effects of Gallopamil in Patients with Fatty Liver DiseaseM Siepmann, B R Rao, W Kirch
European Journal of Clinical Pharmacology|January 29, 1999
Pharmacokinetics and safety of propiverine in patients with fatty liver diseaseM Siepmann, A Nokhodian, D Thümmler, et al.
Pharmacopsychiatry|March 30, 2004
The effects of moclobemide on autonomic and cognitive functions in healthy volunteersM Siepmann, J Handel, M Mueck-Weymann, et al.
Psychopharmacology|October 12, 2001
The effects of reboxetine on autonomic and cognitive functions in healthy volunteersM Siepmann, M Mück-Weymann, P Joraschky, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy menM Siepmann, S Spank, A Kluge, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Deutsche Medizinische Wochenschrift (1946)|December 23, 1994
[Sicca symptoms during systemic therapy with beta-receptor blockers]M Siepmann, J Barth, W Kirch
Medizinische Klinik (Munich, Germany : 1983)|January 15, 1996
[Drug-induced cerebrovascular infarct]U Ebert, M Siepmann, W Kirch
Deutsche Medizinische Wochenschrift (1946)|June 14, 2013
[Medical care of patients with Behçet's disease]A Eichhorn, M Siepmann, W Kirch
British Journal of Clinical Pharmacology|May 1, 1995
The interaction of the calcium antagonist RO 40-5967 with digoxinM Siepmann, C Kleinbloesem, W Kirch
Journal of Cardiovascular Pharmacology|June 1, 1995
Hemolysis on intravenous administration of a new calcium antagonistC H Kleinbloesem, M Siepmann, W Kirch
Clinical Drug Investigation|August 14, 2016
Disposition, Elimination and Haemodynamic Effects of Gallopamil in Patients with Fatty Liver DiseaseM Siepmann, B R Rao, W Kirch
European Journal of Clinical Pharmacology|January 29, 1999
Pharmacokinetics and safety of propiverine in patients with fatty liver diseaseM Siepmann, A Nokhodian, D Thümmler, et al.
Pharmacopsychiatry|March 30, 2004
The effects of moclobemide on autonomic and cognitive functions in healthy volunteersM Siepmann, J Handel, M Mueck-Weymann, et al.
Psychopharmacology|October 12, 2001
The effects of reboxetine on autonomic and cognitive functions in healthy volunteersM Siepmann, M Mück-Weymann, P Joraschky, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy menM Siepmann, S Spank, A Kluge, et al.
Pageof 4